Jim Cramer Recommends Selling These 5 Stocks

Page 5 of 5

1. Seagen Inc. (NASDAQ:SGEN)

Number of Hedge Fund Holders: 66

Jim Cramer on November 3 categorically recommended his viewers to sell biotech company Seagen Inc. (NASDAQ:SGEN)’s stock. Here’s is what Cramer had said:

“I want you to sell the stock on Monday. I don’t trust the FTC, and you’ve made all the big money already.”

Cramer was referring to Pfizer’s $43 billion planned acquisition of Seagen Inc. (NASDAQ:SGEN) which is still under scrutiny by the FTC.

Earlier this month Seagen Inc. (NASDAQ:SGEN) posted Q3 results. GAAP EPS in the quarter came in at -$1.15, missing estimates by $0.37. Revenue in the period jumped 11.9% year over year to $571 million, missing estimates by $64.1 million.

Carillon Eagle Mid Cap Growth Fund made the following comment about Seagen Inc. (NASDAQ:SGEN) in its Q1 2023 investor letter:

Seagen Inc. (NASDAQ:SGEN) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies to treat cancer. During the quarter, a major pharmaceutical company announced plans to buy Seagen for a sizeable premium. The transaction is expected to close late this year or early next year.”

You can also take a peek at 11 Undervalued Mid Cap Stocks To Buy According to Analysts and 12 Most Important Holidays in the US.

Page 5 of 5